MSI Financial Services’s West Pharmaceutical WST Stock Holding History

MSI Financial Services’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$22K	Buy	256 +107	+72%	+$8.41K	﹤0.01%	2349
2016 Q3	$11K	Sell	149 -46	-24%	-$3.65K	﹤0.01%	2754
2016 Q2	$15K	Sell	195 -86	-31%	-$6.26K	﹤0.01%	2526
2016 Q1	$19K	Sell	281 -135	-32%	-$8.12K	﹤0.01%	2350
2015 Q4	$25K	Buy	416 +377	+967%	+$22.7K	﹤0.01%	2182
2015 Q3	$2K	Buy	39 +4	+11%	+$233	﹤0.01%	2813
2015 Q2	$2K	Buy	+35	New	+$1.95K	﹤0.01%	2801

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSI Financial Services's WST Position: Q4 2016 in Review

MSI Financial Services increased its West Pharmaceutical (WST) stake by 72% in Q4 2016, buying an estimated $8.41K and bringing the position to 256 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #2349.

MSI Financial Services first reported a position in WST in Q2 2015 and has held it in 7 quarters since. The position peaked at $25K in Q4 2015. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

MSI Financial Services held 256 shares of West Pharmaceutical worth $22K as of Q4 2016.
MSI Financial Services bought 107 West Pharmaceutical shares in Q4 2016, an estimated $8.41K.
West Pharmaceutical made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2349 holding.
MSI Financial Services first reported a position in West Pharmaceutical in Q2 2015 and has held it in 7 quarters since.
MSI Financial Services's West Pharmaceutical position peaked at $25K in Q4 2015.
288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.